Home › Lung Diseases › Florida › Gainesville
Lung Diseases clinical trials in Gainesville, FL
3 studies for Lung Diseases are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Gainesville
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Gainesville
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 103, Gainesville
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Dallas, TX10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Gainesville
- Heart Failure13 studies
- Breast Cancer12 studies
- Type 1 Diabetes12 studies
- Parkinson's Disease12 studies
- Non-Small Cell Lung Cancer10 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Cancer (all types)9 studies
- Cardiovascular Disease9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Acute Myeloid Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.